Table 2.

ANDV RNA detection in all samples, distributed by the time of the infection.

		BUFFY COAT		PLASMA		GCF		NPS		SALIVA		URINE
		95%(IC)	N/n	95%(IC)	N/n	95%(IC)	N/n	95%(IC)	N/n	95%(IC)	N/n	95%(IC)	N/n
Viral RNA Detection	Acute phase	100(100–98)	154/154	54(45-62)	134/72	30(23-38)	133/40	16(11-23)	131/21	12(7–18)	37/16	13(7–24)	60/8
	Convalescent	96(96–99)	48/46	30(19-45)	43/13	12(5–25)	42/5	2(0–12)	41/1	11(5–23)	44/5	11(0–43)	9/1

From 2008 to 2012, only one sample at hospitalization was collected.

From 2012 to 2015, days 0.7 and 14 after hospitalization, samples, including urine, were collected.

From 2016 to 2022, urine samples were not collected.

The acute and convalescent phases refer to the days 0–16 and 17 and beyond after the first symptoms, respectively.